Associated Papers
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F et al.
Annals of Hematology, 2022
Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.
Yan H et al.
Bioscience Reports, 2020
Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis.
Mohammadi A et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 2019
Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.
Chen Y et al.
Medicine, 2019
Fas and FasL genetic polymorphisms in women with recurrent pregnancy loss: a case-control study.
Han AR et al.
Human Fertility (cambridge, England), 2019
Association between the FAS/FASL Variants and Risk of Male Infertility in Asian Populations; A Systematic Review and Meta-Analysis.
Asgari R et al.
Medicina (kaunas, Lithuania), 2019
The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk.
Wang T et al.
Bioscience Reports, 2019
FAS A-670G and Fas ligand IVS2nt A 124G polymorphisms are significantly increased in women with pre-eclampsia and may contribute to HELLP syndrome: a case-controlled study.
Raguema N et al.
Bjog : an International Journal of Obstetrics and Gynaecology, 2018
Association analysis of FAS-670A/G and FASL-844C/T polymorphisms with risk of generalized aggressive periodontitis disease.
Asgari R et al.
Biomedical Reports, 2018
Quantitative assessment of the relationship between Fas/FasL genes polymorphisms and head and neck cancer risk.
Zhang DF et al.
Medicine, 2018
FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.
Islam Z et al.
Plos One, 2018
Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2017
Fas/FasL gene polymorphism in patients with Hashimoto's thyroiditis in Turkish population.
Erdogan M et al.
Journal of Endocrinological Investigation, 2017
Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.
Zhu A et al.
Rheumatology International, 2016
Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
Zhang M et al.
Cancer Medicine, 2016
Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
Zhang F et al.
International Journal of Cancer, 2015
The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa.
Chattopadhyay K et al.
Bmc Cancer, 2015
FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
Santos M et al.
Journal of Affective Disorders, 2015
Fas gene variants in childhood acute lymphoblastic leukemia and association with prognosis.
Valibeigi B et al.
Pathology Oncology Research : Por, 2014
Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2014
Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y et al.
Plos One, 2014
Soluble fas and the -670 polymorphism of fas in lupus nephritis.
Bollain-Y-Goytia JJ et al.
International Journal of Nephrology, 2014
Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S et al.
Rheumatology International, 2013
Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y et al.
Gynecologic Oncology, 2013
Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis.
Xiang N et al.
Molecular Biology Reports, 2013
Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
Sun Z et al.
Connective Tissue Research, 2013
Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
Kobak Ş et al.
Reumatismo, 2012
Fas, Fas Ligand, and vitamin D Receptor FokI gene polymorphisms in patients with type 1 diabetes mellitus in the Aegean region of Turkey.
Sahin SB et al.
Genetic Testing and Molecular Biomarkers, 2012
Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysis.
Lu MM et al.
Experimental and Therapeutic Medicine, 2012
Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A et al.
Genetic Testing and Molecular Biomarkers, 2012
FAS-670A/G single nucleotide polymorphism may be associated with human T lymphotropic virus-1 infection and clinical evolution to TSP/HAM.
Vallinoto AC et al.
Virus Research, 2012
A Fas gene polymorphism influences herpes simplex virus type 2 infection in South African women.
Chatterjee K et al.
Journal of Medical Virology, 2010
Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
Zhou RM et al.
Journal of Gastroenterology and Hepatology, 2010
Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
Arasteh JM et al.
Immunological Investigations, 2010
A single-nucleotide polymorphism (-670) of the maternal Fas gene is associated with intrauterine growth restriction.
Robinson R et al.
American Journal of Obstetrics and Gynecology, 2009
The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
Broen J et al.
Arthritis and Rheumatism, 2009
Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans.
Chatterjee K et al.
Bmc Research Notes, 2009
A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.
Hofmann G et al.
Journal of Cellular and Molecular Medicine, 2009
FAS and FAS ligand polymorphisms in the promoter regions and risk of gastric cancer in Southern China.
Wang M et al.
Biochemical Genetics, 2009
FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z et al.
Carcinogenesis, 2009
Effect of Fas -670 A/G gene polymorphism on corneal allograft endothelial rejection.
Jahadi Hosseini HR et al.
Iranian Journal of Immunology : Iji, 2009
Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis.
Li M et al.
The Journal of Investigative Dermatology, 2008
Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
Wu F et al.
American Journal of Industrial Medicine, 2008
[Polymorphisms of FAS and FASL genes and susceptibility of silicosis].
Wu F et al.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases, 2008
Association between FAS polymorphism and prostate cancer development.
Lima L et al.
Prostate Cancer and Prostatic Diseases, 2008
Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.
Erdogan M et al.
Journal of Endocrinological Investigation, 2007
Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients.
Girnita DM et al.
Transplantation, 2006
Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C et al.
Pharmacogenetics and Genomics, 2006
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C et al.
Pharmacogenetics and Genomics, 2006
[Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
Yang S et al.
Zhonghua Yi Xue Za Zhi, 2005